| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, January 04, 2017 4:01:54 PM
Apologies, I was thinking you were speaking generally. You have calls added to a fundamentally long position. I hear you. Adds some fizz, no doubt.
My post was not intended to attack, just to indicate that calls are not something I tend to trade in, no matter what the news is, given what really happens. I know the brokerages love to sell them, and "traders" love to talk them up. But traders are traders. They eat what they can kill. I try to avoid that mindset because the short-term nature of it creates pressures I'd rather avoid when making sound long-term investment decisions.
On the other hand, honestly, given how the market operates these days, it's almost a given that all of these companies are run down, unless they start really start high (ala Juno), with big players already invested. So I effectively am buying "calls" with my very, very cheap shares. I waited a long time to get in here, because I didn't like what the shorts were doing, and I was busy elsewhere to get into a company far from results. The market cap now, at $50 million or so, is low, and makes a real pop here very substantial potentially. So that's what makes the share ownership similar to a call. But at the end of the day, 30-50 million, maybe 25 million, the market cap is still in a range. Dilution becomes the issue, though right now, with 10 million in the bank, I'm feeling it's not a bad time to hold for now, given pending news.
I evaluate differently than others. I also think this is why the shorts are all over this board right now. They know getting this market cap down now is hard, and it's more likely to drift upwards, without news, as speculation builds.
My post was not intended to attack, just to indicate that calls are not something I tend to trade in, no matter what the news is, given what really happens. I know the brokerages love to sell them, and "traders" love to talk them up. But traders are traders. They eat what they can kill. I try to avoid that mindset because the short-term nature of it creates pressures I'd rather avoid when making sound long-term investment decisions.
On the other hand, honestly, given how the market operates these days, it's almost a given that all of these companies are run down, unless they start really start high (ala Juno), with big players already invested. So I effectively am buying "calls" with my very, very cheap shares. I waited a long time to get in here, because I didn't like what the shorts were doing, and I was busy elsewhere to get into a company far from results. The market cap now, at $50 million or so, is low, and makes a real pop here very substantial potentially. So that's what makes the share ownership similar to a call. But at the end of the day, 30-50 million, maybe 25 million, the market cap is still in a range. Dilution becomes the issue, though right now, with 10 million in the bank, I'm feeling it's not a bad time to hold for now, given pending news.
I evaluate differently than others. I also think this is why the shorts are all over this board right now. They know getting this market cap down now is hard, and it's more likely to drift upwards, without news, as speculation builds.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
